by altering cellular redox potential via reactive oxygen species (ROS) production. 1, 2 The aforementioned mechanism can help to explain a variety of cardiovascular diseases caused by mitochondrial dysfunction. In this review article, we focus on the mechanism of ROS production by the mitochondrial electron transport chain (ETC), the related physiological implications, and how these mechanisms control the disease process of myocardial infarction.
Mitochondrial energy transduction for ATP synthesis is driven by the oxidation of NADH and FADH 2 , which is performed by the ETC located within the inner membrane ( Figure 1) . The ETC mediates a stepwise electron flow from NADH or succinate to molecular oxygen through a series of electron carriers including complex I, complex II, ubiquinone, complex III, cytochrome c, and complex IV. Electron flow mediated by the ETC can drive proton translocation from the matrix side to the cytoplasmic side. ATP synthesis is then catalyzed by F 0 F 1 ATPase driven by the flow of protons back across the membrane. This process is called oxidative phosphorylation.
Oxidative Phosphorylation Is an Endogenous
Source of ROS Chance and Williams 3, 4 have proposed a convention following the typical order of addition of agents during an experiment using the Clark oxygen electrode, which allows definition of the so-called respiratory states and determination of the respiratory control index. In this experiment, mitochondria were added to an oxygen electrode chamber, followed by a mixture of glutamate and malate (NADH-linked; explained in Online Figure I) or succinate (FADH 2 -linked) as substrate.
Respiration is slow (state 2 respiration) because of a low amount of ADP and that the proton circuit is not completed by H + re-entry through F 0 F 1 ATPase. A limited amount of ADP is added, allowing F 0 F 1 ATPase to synthesize ATP coupled to proton re-entry across the membrane, which is defined as state 3 respiration. Oxygen uptake is accelerated during state 3 respiration, and the total oxygen uptake is effectively used for ATP synthesis. When ADP is exhausted, respiration slows and finally anoxia is attained, which is state 4 respiration. State 4 respiration is not ADP-dependent and technically can be attained by oligomycin, an F 0 F 1 ATPase inhibitor. In myocytes, the mitochondria comprise 30% to 40% of the volume and generate ≈90% of ATP. 5 The mitochondria are also the major source of ROS in the cardiovascular system. 5 Under most physiological conditions, electron transport to O 2 is tightly coupled to oxidative phosphorylation for ATP synthesis. However, oxidative phosphorylation is the major endogenous source of ROS, such as • O 2 − (superoxide anion radical), H 2 O 2 , and • OH (hydroxyl radical), which are toxic byproducts of respiration. 1,2 • O 2 − generation by mitochondria is primarily by electron leakage from the ETC (Figure 1 ). Under the physiological conditions of state 4 respiration, oxygen tension in the mitochondria is low; O 2 consumption by the ETC does not meet the needs of oxidative phosphorylation. A decrease in the rate of mitochondrial phosphorylation increases electron leakage from the ETC and subsequent production of
is converted to H 2 O 2 by mitochondrial MnSOD (SOD2) as in Equation 1 , and H 2 O 2 is further converted to H 2 O by glutathione peroxidase in the presence of glutathione (GSH in Equation 2 ). It was estimated that the mitochondria produce ≈0.5 nmol H 2 O 2 /min per milligram of protein, accounting for 2% of oxygen uptake, under the conditions of state 4 respiration. 6 Metabolic H 2 O 2 under state 3 and 4 respiration may modestly induce mitochondrial oxidative stress or diffuse to the cytosol, acting as a signaling molecule to trigger important physiological responses, such as endothelium-derived hyperpolarizing factor that mediates shear or acetylcholine-induced smooth muscle relaxation in small arteries. 7, 8 
The mitochondrial ETC proteins are rich in metal cofactors such as hemes (complexes II, III, and IV) and iron-sulfur clusters (complexes I, II, and III). Oxidative stress in the mitochondria can be greatly enhanced in the presence of reduced transition metals because H 2 O 2 can be converted to the highly reactive hydroxyl radical (HO • ) via the Fe 2+ -dependent Fenton reaction (Equation 3) or via the Fe 3+ -catalyzed Haber-Weiss mechanism (Equation 4). Under pathophysiological conditions of cardiovascular disease, decreased or impaired functioning of the ETC and oxidative phosphorylation increases mitochondrial ROS production. Acute ROS exposure can inactivate the iron-sulfur centers of complexes I, II, and III, and Krebs cycle aconitase, resulting in the shutdown of mitochondrial energy production, and chronic ROS exposure can result in oxidative damage to mitochondrial and cellular proteins, lipids, and nucleic acids. Therefore, oxidative stress induced by ROS overproduction in the mitochondria is closely associated with disease pathogenesis. proton pumping and represents the potential energy driving proton re-entry to the matrix for ATP synthesis. Δp consists of a membrane potential (∆Ψ) and a proton gradient (∆pH), which partially contribute to the source of • O 2 − mediated by the mitochondria (Figure 1 ). In vitro studies have firmly established the effect of membrane potential on • O 2 − production by complex III. [9] [10] [11] The production of • O 2 − mediated by isolated mitochondria under the conditions of state 2 respiration can be induced by glutamate plus malate and measured by electron paramagnetic resonance (EPR) spin trapping with 5′,5′-dimethyl pyrroline N-oxide. The addition of ADP dissipates the proton gradient, initiates the conditions of state 3 respiration, and diminishes mitochondria-mediated • O 2 − generation, indicating that the coupling of enhanced O 2 consumption with oxidative phosphorylation decreased electron leakage, and a decrease in ∆pH is correlated with decreasing • O 2 − generation by the mitochondria. The addition of oligomycin A inhibits the F 0 F 1 ATPase activity and initiates the conditions of state 4 respiration, which gradually restores ΔpH and ΔΨ. Because of restored Δp, • O 2 − generation induced by glutamate plus malate at state 4 respiration is enhanced to the level of state 2 respiration. The addition of carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone, a proton ionophore, to the mitochondria uncouples oxidative phosphorylation, which dissipates ΔΨ and ΔpH. EPR analysis indicated that proton ionophore reduces mitochondria-mediated • O 2 − production to the level of state 3 respiration. The analysis of H 2 O 2 production by isolated mitochondria indicated that the rate of • O 2 − generation by the ETC is decreased by uncouplers or inhibitors of Δp. 12, 13 Therefore, increasing ΔΨ and ∆pH-supported proton backpressure induced electron leakage from the normal pathway for • O 2 − production in the mitochondria.
Membrane Potential and Proton Gradient as Sources of ROS

Factors Involved in • O 2 − Generation Mediated by the ETC
Under normal physiological conditions, a decrease in the rate of oxidative phosphorylation can increase oxygen free radical production, in the form of • O 2 − , from the early stages of the ETC. Two segments of the ETC have been widely hypothesized to be responsible for • O 2 − generation. One, on the NADH dehydrogenase (NDH; or flavin subcomplex) of complex I, operates via electron leakage from the reduced flavin mononucleotide. 14, 15 The other, on complex III, mediates • O 2 − production through a Q-cycle mechanism, in which electron leakage results from auto-oxidation of ubisemiquinone 16 and reduced cytochrome b (low potential b 566 or b L ). 11 Furthermore, an increasing body of evidence links • O 2 − overproduction with complex II 17, 18 or a defect in complex II. 19, 20 Under ischemic conditions, phosphorylation of complex IV may also increase electron leakage and • O 2 − production. 21 Therefore, mediation of • O 2 − production by complex II or complex IV is relevant in disease conditions. Figure 1. Schematic of the mechanism of oxygen free radical(s) generation mediated by electron transport chain, the proton motive force (PMF, Δp), and aconitase of Krebs cycle in the mitochondria. Blue arrows show the path of electron transport from NADH or FADH 2 to O 2 , or reverse electron flow from FADH 2 -linked succinate to complex I. Brown dashed arrows indicate the sites mediating • O 2 − generation in the mitochondria. As electrons pass through the chain, protons are pumped from the mitochondrial matrix to the intermembrane space, thereby establishing an electrochemical potential gradient or PMF (Δp) across the inner membrane. Positive and negative charges on the membrane denote the membrane potential (ΔΨ). A proton gradient is denoted by ΔpH for the difference of pH across the membrane. Δp can contribute to • O 2 − generation in the respiratory conditions of state 2 and state 4. Black circles show aconitase of the Krebs cycle that generates NADH and FADH 2 as substrates of electron transport chain that are the source of hydroxyl radical production induced by • O 2 − . The common inhibitors used for studying the ETC components, ΔpH, and ΔΨ are indicated in brick red italics. DPI indicates diphenyleneiodinium chloride; and TTFA, 2-thenoyltrifluoroacetone.
Mediation of • O 2 − Generation by Complex I
Mitochondrial complex I (EC 1.6.5.3-NADH:ubiquinone reductase [NQR]) is the first energy-conserving segment of the ETC. Purified bovine heart complex I contains 45 different polypeptides with a total molecular mass approaching 980 kDa. 22 Complex I can be resolved into 3 subcomplexes using a chaotropic agent: a flavoprotein fraction, an ironsulfur protein fraction, and a hydrophobic fraction. The flavoprotein fraction contains the catalytic activity of NDH or NADH ferricyanide reductase. The redox centers, apart from the flavin mononucleotide (FMN), are iron-sulfur centers, which cannot be studied by optical spectroscopy but instead require the more labor-intensive technique of low-temperature EPR. 23 Complex I catalyzes the transfer of 2 electrons from NADH to ubiquinone in a reaction that is coupled with the translocation of 4 protons across the membrane, and it is inhibited by rotenone and piericidine A (Table) . The redox centers of mammalian complex I that are involved in the mediation of 2-electron transfer include a noncovalent FMN, 8 iron-sulfur clusters, and ubiquinone. Current evidence suggests that proton translocation stoichiometry is 4H + /2e − . In addition to electron transfer and energy transduction, the catalysis of complex I provides the major source of ROS generation in the mitochondria with detectable • O 2 − formed under the conditions of enzyme turnover. [24] [25] [26] Studies using isolated mitochondria indicate that • O 2 − and H 2 O 2 production by complex I are mainly controlled by NADH/NAD + redox coupling and succinate-induced reverse electron transfer. 13, 27 Two segments of complex I are widely recognized to be responsible for enzyme-mediated • O 2 − generation. One is involved in the cofactor of FMN and FMN-binding moiety at the 51 kDa polypeptide (FMN-binding subunit), [28] [29] [30] [31] and the other is located on the ubiquinone-binding site that mediates ubiquinone reduction.
ROS Generation by the FMN Moiety of Complex I
The mechanism of • O 2 − generation is likely derived from 1-electron transfer of reduced FMN (FMNH 2 ) to molecular oxygen. 30 Based on investigations using models of intact complex I and its flavoprotein fraction subcomplex (NDH) along with EPR spin trapping with 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide, enzyme-mediated • O 2 − generation by intact complex I or NDH isolated from bovine heart can be inhibited by the general flavoprotein inhibitor diphenyleneiodinium chloride. The addition of free FMN can increase enzyme-mediated • O 2 − generation by intact complex I or NDH. 28 However, FMN addition could not reverse the inhibition by either diphenyleneiodinium chloride treatment or heat denaturation of either intact complex I or NDH. These results support the involvement of FMN and the FMN-binding protein moiety in the mediation of • O 2 − generation by the flavoprotein fraction of complex I. More evidence has been provided by redox titration of mitochondrial • O 2 − generation using submitochondrial particles. 29 The redox potential of • O 2 − production at the site of complex I was determined to be ≈−295 mV. The midpoint potential of the • O 2 − producing site at complex I resembles the value of free FMN (≈−310 mV for the redox couple of FMN/ FMNH •− ), also supporting the FMN moiety as a potential site of • O 2 − generation. 
ROS Generation by the Ubiquinone-Binding Domain of Complex I
The second site associated with complex I-mediated • O 2 − generation has been proposed to be the site of ubiquinone reduction because of the formation of an unstable ubisemiquinone radical (SQ) that is the source of • O 2 − . 13, 27, 32, 33 The ubisemiquinone radical is formed via incomplete reduction of ubiquinone under the conditions of enzyme turnover. Evidence of SQ involvement has been investigated using EPR detection of enzymatic systems in the presence or absence of spin trap. 25 SQ can be categorized as stable ubisemiquinone radical that is EPRdetectable and unstable ubisemiquinone radical that is not detected by EPR because of a short half-life at room temperature. Unstable ubisemiquinone radical is thus a source of • O 2 − under physiological conditions. Studies using isolated complex I and EPR spin trapping indicated that enzyme-mediated • O 2 − generation driven by NADH was enhanced 2-fold in the presence of ubiquinone-1 (Q 1 ) compared with that in the absence of Q 1 . More than 80% of the enhanced • O 2 − generation can be inhibited by rotenone, thus supporting a • O 2 − generation mechanism involving the reduction of ubiquinone to an unstable semiquinone radical. 25 The formation of an unstable semiquinone radical under enzyme turnover conditions is likely mediated through the ubiquinone-binding site of the hydrophobic fraction subcomplex in complex I. Ohnishi et al 35 have reported the presence of 2 distinct semiquinone species with different spin relaxation times in complex I in situ based on a study using the submitochondrial particle from rat heart 34 and proteoliposomes of isolated complex I. The unstable semiquinone as a source of
− is likely to be SQ Nf (semiquinone with fast relaxing time), which is highly sensitive to rotenone or piericidin A.
Studies from Lambert and Brand 27 using isolated mitochondria suggest that • O 2 − production from the ubiquinone moiety of complex I is large under conditions of reverse electron transport mediated by respiring to succinate 13 or conditions of forward electron transport in the presence of ATP and piericidin A (or rotenone). • O 2 − generation by complex I during reverse/forward electron transport can be inhibited by uncoupler and nigericin, suggesting that • O 2 − production by complex I is more dependent on ΔpH than ΔΨ. 13, 27 Note that nigericin is an ionophore functioning as a specific carrier of protons and catalyzing a K + /H + exchange that abolishes ΔpH, thus allowing ΔΨ to increase to the full magnitude of the proton motive force. Whereas, an uncoupler [eg, carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone] functions as a carrier of protons and charge that collapses both ΔpH and ΔΨ.
Role of Iron-Sulfur Clusters in ROS Generation by Complex I
Mammalian complex I hosts as many as 8 iron-sulfur clusters, which are essential redox centers controlling electron transfer during enzyme turnover. Iron-sulfur clusters identified with the use of EPR include the binuclear clusters N1a and N1b and the tetranuclear clusters N2, N3, N4, and N5. Two more tetranuclear clusters, N6a and N6b, were identified in the subunit TYKY. Based on the x-ray structure of complex I from Thermus thermophilus, the organization of iron-sulfur clusters in mammalian complex I has been inferred. The main route for electron transfer within the enzyme is likely to be NADH→FMN→N3→N1b→N4→N5→N6a→N6b→N2→ ubiquinone. 36 The iron-sulfur clusters in complex I should play a secondary role in the generation of • O 2 − by complex I. Studies using intact mitochondria from rat brain indicate that rotenone-insensitive • O 2 − generation by complex I is far less sensitive to p-chloromercuriobenzoate (an iron-sulfur cluster blocker) treatment than to diphenyleneiodinium chloride treatment. 29 However, several research groups have proposed that in intact mitochondria and submitochondrial particles, most of the • O 2 − may be generated around the N2/ubiquinone site, suggesting that electron leakage at the N2 center is coupled to incomplete reduction of ubiquinone. 32 The 75 kDa subunit hosts 3 iron-sulfur clusters (N1b, N4, N5) of mammalian complex I. Residues 100 to 120 of the 75-kDa protein precursor, 100 WNILTNSEKTKKAREGVMEFL 120 (peptide of p75), exhibit a β-sheet-α-turn-helix conformation (blue region in the homolog model of 75 kDa subunit in Figure 2B ). The peptide of p75 was designed as a B-cell epitope to make an antibody that has been used to probe the structure and function of complex I. 25, 37 The polyclonal antibody Figure 2 . A, Homology model of the 51 kDa subunit of bovine heart complex I using the crystal structure of respiratory complex I from Thermus thermophilius, with a protein data bank accession code 3I9V, as a template. 36 Arrows show the domains of peptide pGSCA206 and peptide p51, denoted by green and blue ribbons. B, Model of the 75 kDa subunit of bovine heart complex I using 3I9V as a template. Arrows show the domains of peptide pGSCB367 and peptide p75, denoted by red and blue ribbons. generated against p75 is named Ab75. The binding of Ab75 antibody to mammalian complex I resulted in the inhibition of • O 2 − generation by 35% as measured by EPR spin trapping. 25 Therefore, (1) the binding of Ab75 is likely to stabilize the conformation of protein matrix surrounding the iron-sulfur clusters, thus enhancing electron transfer efficiency; and (2) Ab75 binding may protect the protein matrix from molecular oxygen accessing the iron-sulfur clusters, including N1b, N4, and N5 in bovine complex I ( Figure 2B ), minimizing electron leakage from iron-sulfur clusters.
Role of Cysteinyl Redox Domains
The mitochondrial redox pool contains a high physiological concentration of glutathione. The overproduction of • O 2 − and
-derived oxidants increases the ratio of oxidized glutathione to glutathione. Moreover, the proteins of mitochondrial ETC are rich in protein thiols. Mammalian complex I is a major component of the ETC to host the reactive/regulatory thiols that are thought to function in antioxidant defense and redox signaling. Physiologically, the complex I-derived regulatory thiols have been implicated in the regulation of respiration, NO utilization, and redox status of the mitochondria. It is documented that the 51 kDa (FMN-binding protein) and 75 kDa (iron-sulfur protein) subunits of complex I are the 2 major polypeptides hosting redox thiols. [24] [25] [26] 28, [38] [39] [40] The C 206 (Cys 206 ) moiety of 51 kDa subunit plays a unique role as a redox thiol in oxidative damage to complex I. The C 206 of 51 kDa subunit is also involved in sitespecific S-glutathionylation (via binding of glutathione). 24, 26 The peptide identified to form and bind glutathione is 200 GAGAYIC 206 GEETALIESIEGK 219 , which is highly conserved in bacterial, fungal, and mammalian enzymes. 28 An x-ray crystal structure of the hydrophilic domain of complex I from T.thermophilus reveals that this conserved cysteine (Cys 182 in T.thermophilus) is only 6 Å from the FMN, which is consistent with the role of C 206 as a redox-sensitive thiol and FMN serving as a source of • O 2 − . 36 The polypeptide of 75 kDa is the other subunit of complex I to be involved in redox modification via S-glutathionylation or protein thiyl radical formation. 24, 26, 40 Based on LC/MS/ MS analysis, S-glutathionylation of C 367 can be induced by oxidized glutathione through protein thiol disulfide exchange. C 554 and C 727 were S-glutathionylated when complex I of rat heart mitochondria was oxidatively stressed by diamide. 40 The glutathione-binding peptides identified include 361 VDSDTLC 367 TEEVFPTAGAGTDLR 382 , 544 MLFLLGADGGC 554 ITR 557 , and 713 AVTEGAHAVEEPSIC 727 . Based on EPR spin trapping studies, oxidized glutathioneinduced S-glutathionylation of complex I at the 51 kDa and 75 kDa subunits affects the • O 2 − generation activity of complex I by marginally decreasing electron leakage and increasing electron transfer efficiency. 26 High dosage of oxidized glutathione or diamide-induced S-glutathionylation tends to decrease the catalytic function of complex I and increase enzyme-mediated • O 2 − generation. 38, 40 The binding of antibodies against the peptide of 200 GAGAYIC 206 GEETALIESIEGK 219 (pGSCA206 in Figure 2A ) decreases complex I-mediated • O 2 − generation by 37%. 25 Because FMN serves as a source of • O 2 − , the binding of antibodies may prevent molecular oxygen from accessing FMN, resulting in a subsequent decrease in • O 2 − production. In addition, the binding of antibodies against the peptide of 354 LKDLLNKVDSDTLC 367 TEEVF 372 (pGSCB367 in Figure 2B ) inhibits • O 2 − production by complex I by 57%. The distance of pGSCB367 to iron-sulfur clusters is relatively long; thus, the binding of antibodies to the 75 kDa subunit of complex I likely triggers long-range conformational changes in the 75 kDa polypeptide to reduce O 2 interactions. The binding of either antibody does not affect the electron transfer activity of complex I. Therefore, the redox domains involved in S-glutathionylation are responsible for regulating electron leakage for • O 2 − production by complex I. The catalysis of complex II is thought to contribute to ROS generation in mitochondria. Two regions of the enzyme complex are responsible for generating • O 2 − . One is located on the FAD cofactor, whereas the other is located on the ubiquinone-binding site, which acts in the mediation of ubiquinone reduction. 17, 41 
Mediation of
ROS Generation by the FAD Moiety of Mammalian Complex II
The generation of • O 2 − by the FAD moiety of complex II may arise from FADH 2 auto-oxidation or FADH •− semiquinone auto-oxidation. Evidence has been provided from the mammalian enzyme via the use of inhibitor 2-thenoyltrifluoroacetone (TTFA). 42, 43 TTFA is a classical inhibitor for the ubiquinone reduction of complex II by occupying its ubiquinone-binding sites. 20 Therefore, the binding of TTFA to the enzyme induces electron accumulation at the early stage of complex II. Based on EPR spin trapping studies using isolated complex II and a supercomplex (succinate cytochrome c reductase) hosting complex II and complex III, the inhibitory effect of TTFA on • O 2 − generation by complex II or succinate cytochrome c reductase indicated that FADH 2 auto-oxidation mediated by FAD-binding moiety partially contributes to • O 2 − production. 43 The production of • O 2 − by complex II or succinate cytochrome c reductase is minimized under the conditions of enzyme turnover. 42, 43 
ROS Generation by the Ubiquinone-Binding Site of Complex II
Mammalian complex II contains ≥2 ubiquinone-binding sites (namely, Qp and Qd). 20 Qp is near the matrix side, January 31, 2014
and Qd is near the intermembrane space site. 20 Because the ubiquinone-binding site in complex II is close to the TTFA-binding site, the EPR signal derived from ubisemiquinone of complex II is sensitive to TTFA. 44 The location of Qp site and its quinone-binding pocket has been revealed by the x-ray structure of porcine heart complex II (protein data bank, 1ZOY). The amino acid residues involved in the quinone-binding pocket at Qp site form the quinone-binding environment (Figure 3 ). 20, 41 Under physiological conditions, ubiquinone reduction mediated by complex II is well controlled via the quinone-binding environment. The alteration of the quinone-binding environment results in incomplete reduction of ubiquinone, leading to increased ROS production.
Mediation of • O 2 − Generation by Complex III
Q-Cycle Mediated by Complex III
Mitochondrial complex III catalyzes electron transfer from ubiquinol (QH 2 ) to ferricytochrome c, which is coupled to proton translocation for ATP synthesis. The redox centers of complex III consist of QH 2 ; hemes b L , b H (high potential b or b 562 ), and c 1 ; and the Rieske iron-sulfur protein. The electron transfer from QH 2 to cytochrome c follows the Q-cycle mechanism.
In the Q-cycle mechanism, there are 2 semiquinones formed in different parts of the cycle ( Figure 4A ). An unstable semiquinone ( • Q o − ) is formed near the cytoplasmic site (outer site or positive site). The other semiquinone ( • Q i − ), formed near the matrix side (inner site or negative site), is a stable semiquinone and EPR-detectable. During the enzyme turnover of complex III, 1 electron from QH 2 is sequentially transferred to Rieske iron-sulfur protein, then cytochrome c 1 , and then ferricytochrome c. QH 2 contains 2 electrons, but cytochrome c only accepts 1 electron. This leaves an unstable semiquinone ( • Q o − ) formed at the cytoplasmic site. One electron from the unstable semiquinone is transferred to b L , and then transferred to b H . One electron from b H is then transferred to ubiquinone (Q) to form a stable semiquinone at the matrix side. The stable semiquinone can accept 1 electron from a second single turnover to complete the cycle, forming QH 2 .
• O 2 − Generation by the Q-Cycle
The Q-cycle mechanism provides an important theoretical basis to explain why mammalian complex III is an endogenous source of ROS in mitochondria. 9, 43, 45, 46 • Q o − formed near the cytoplasmic space is a source of • O 2 − because of its poor stability. Antimycin A, myxothiazol, and stigmatellin are inhibitors of complex III ( Figure 4A ). The mechanism of inhibition by these 3 inhibitors strongly supports Q o site as the source of 
Role of Cytochrome b L and Membrane Potential in • O 2 − Generation by Complex III
As indicated in Figure 4A of the Q-cycle mechanism, b L accepts 1 electron from the unstable semiquinone. The midpoint potential of b L is −50 mV, which tends to donate an electron. In vitro evidence supports the notion of ferrocytochrome b L to be a source of • O 2 − . 43, 47 Experimental evidence has shown the involvement of • O 2 − generation during intramolecular electron transfer from ferrocytochrome b to ferricytochrome c 1 . 43 In vitro studies using the vesicles of phospholipid-reconstituted complex III indicated that the rate of • O 2 − generation can be controlled by the modulation of ΔΨ. 10 Experimental evidence has revealed that the rate of • O 2 − generation by phospholipid-reconstituted complex III is enhanced exponentially by increased ΔΨ and nigericin treatment, 10 Figure 4A ).
Bidirectionality of Superoxide Release as Mediated by Complex III
Because the anionic form of • O 2 − is too strongly negatively charged to readily pass the inner membrane, • O 2 − production mediated by complex III can exhibit a distinct membrane sidedness or topology. The Q o site, one of the sources of • O 2 − , is located near the intermembrane space ( Figure 4B ). The close proximity of the Q o site to the intermembrane space can result in invariable release of a fraction of complex III-derived • O 2 − to the cytoplasmic side of the inner membrane. 48, 49 Experimental evidence has supported that ≈50% of total electron leakage in the mitochondria lacking CuZn-SOD accounts for extramitochondrial • O 2 − release. 50 The remaining ≈50% of electron leakage is because of is released to both sides of the inner mitochondrial membrane by semiquinone at the Q o site. 49, 50 
Protein-Protein Interaction With Complex I Minimizes
Hyperphosphorylation of Complex IV Increases Enzyme-Mediated ROS Generation
Mitochondrial complex IV is cytochrome c oxidase that catalyzes the sequential transfer of 4 electrons from ferrocytochrome c to O 2 , forming 2H 2 O. The reduction of O 2 to H 2 O provides the driving force for proton translocation and ATP synthesis. The catalytic function of complex IV is mainly controlled by subunit I and subunit II with both subunits encoded by mitochondrial DNA. 52, 53 The redox centers of complex IV include 2 Cu A (in a cluster with sulfur atoms in subunit II), 2 a-type hemes (heme a and heme a 3 are located in subunit I), and Cu B (in subunit I). Subunit II is the location of 2 Cu A sites that undergo a 1-electron oxidation-reduction reaction. The binuclear Cu A center receives electrons, 1 at a time, from ferrocytochrome c. One axial coordination position to the iron of heme a 3 is not occupied by an amino acid ligand. This is the position where oxygen binds before its reduction to water. Heme a 3 is also the site of binding of several inhibitors, including cyanide, azide, NO, and CO. Cu B , the third copper, is immediately adjacent to heme a 3 ; it has 3 histidine ligands, suggesting that a fourth coordination position may be occupied by a reaction product during a specific stage of the oxygen-reduction reaction. One of 3 ligands, histidine-240 (H 240 in bovine heart complex IV), is crosslinked to a nearby specific tyrosine residue (Y 244 in bovine heart complex IV) through a covalent bond. This specific tyrosine has been proved to participate in the formation of a protein-tyrosyl radical intermediate [54] [55] [56] Cu B and nearby heme a 3 form the binuclear center, which tightly controls oxygen binding, formation of intermediates (oxy, compound P, and compound F), and reduction of oxygen to H 2 O. Electron leakage for • O 2 − generation is not likely occurring during the enzyme turnover of complex IV or under normal physiological conditions. However, • O 2 − production can be mediated by hyperphosphorylated complex IV under ischemic conditions. 21
Aconitase Is a Source of Hydroxyl Radical
Mitochondrial aconitase hosts a [4Fe-4S] cluster in its active site, which catalyzes the conversion of citrate to isocitrate (a reaction of stereospecific hydration and rehydration) in the Krebs cycle. Aconitase activity in the mitochondria was reported to be a redox sensor of ROS. [57] [58] [59] The reaction of aconitase with superoxide (k≈10 7 M -1 per second) rapidly inactivates its enzymatic activity by producing an inactive [3Fe-4S] cluster (g=2.018), free iron (II), and H 2 O 2 . Consequently, the inactivation of mitochondrial aconitase by superoxide facilitates the formation of hydroxyl radical via a Fenton-type mechanism (Figure 1 ). 60
Effects of Mitochondrial ROS in the Heart and Role in Disease
Effects of Mitochondrial ROS on Myocytes
The heart requires a constant supply of energy to support contractile activity. This obligation is met by the daily synthesis of ATP via oxidative phosphorylation. In normal heart, ≈70% of ATP requirement is met by the catabolism of free fatty acids via β-oxidation, giving rise to a greater ATP yield than with glucose. Oxidative phosphorylation is the endogenous source of mitochondrial ROS production, and the overproduction of ROS can establish a vicious cycle of oxidative stress in the mitochondria and mitochondrial permeability transition induction with ROS-induced ROS release, 61 which has important pathophysiological effects. Excess ROS production under pathophysiological conditions executes the detrimental effects on myocytes via mitochondrial dysfunction and bioenergtic decline. The chronic exposure of myocytes to ROS leads to the impairment of excitation-contraction coupling, causing arrhythmias and contributing to cardiac remodeling by inducing cardiac hypertrophy, apoptosis, necrosis, and fibrosis. [62] [63] [64] 
Effects of Mitochondrial ROS on Endothelial Cells
In the vasculature, excess production of ROS from the mitochondria is responsible for the inflammatory vascular reaction that has been implicated in the pathogenesis of atherosclerosis, hypertension, diabetes mellitus, 65 and corruption of coronary collateral growth. 66 However, basal low levels of mitochondrial ROS released under normal metabolic activity may exert beneficial effects on cardiovascular physiology and function. 7 Myocardial or cardiac work is tightly controlled by the coronary blood flow and heart rate. In the endothelium of coronary arterioles, the generation of H 2 O 2 in mitochondria is induced by shear stress. Mitochondrial H 2 O 2 subsequently mediates flow-induced dilation of vessel via the activation of large-conductance Ca 2+ -activated potassium channel coupled with intracellular signaling of protein kinase A-1α activation in the smooth muscle cells. 8,67 H 2 O 2 produced in response to flow was demonstrated to be a byproduct of complex I and complex III from the endothelial ETC. 8 Therefore, H 2 O 2 originating from mitochondrial • O 2 − in the vasculature has been described as an endothelium-derived hyperpolarizing factor that acts as an intracellular signaling molecule to mediate shear-or acetylcholine-induced smooth muscle relaxation 8 (Figure 5 ).
In the cardiac myocytes, H 2 O 2 derived from mitochondrial • O 2 − has also been proposed to regulate collateral blood flow via underlying diffusion to the microvascular system of the heart. 68 This has important physiological implications providing a link between mitochondrial H 2 O 2 and metabolic flow regulation and couples the production of H 2 O 2 as an endothelium-derived hyperpolarizing factor to myocardial metabolism. Evidence has indicated that mitochondrial H 2 O 2 is the vasoactive product of metabolically active cardiac myocytes, functioning as a coronary metabolic dilator coupling myocardial oxygen consumption to coronary blood flow in a redox-dependent manner. The above coronary metabolic dilation is mediated by the activation of voltage-dependent potassium channels and thiol redox-dependent signaling. 69, 70 Therefore, it is expected that metabolic H 2 O 2 produced by increased perfusion during intense exercise likely contributes to endothelium-dependent hyperpolarization.
Role of Mitochondrial ROS in Myocardial Infarction
Mitochondrial dysfunction is a critical consequence of myocardial infarction. Impairment of mitochondrial function during myocardial ischemia/reperfusion injury is caused by oxidative stress. [71] [72] [73] [74] [75] In the ischemic heart, oxygen delivery to the myocardium is not sufficient to meet the need for substrate oxidation in mitochondria during the physiological conditions of hypoxia, leaving mitochondrial ETC in a highly reduced state. This results in increased electron leakage from the ETC that in turn reacts with residual O 2 to give • O 2 − . Ischemia converts most ATP to ADP and AMP. On reperfusion, most ADP is converted back to ATP and AMP as catalyzed by adenylate kinase. Because of the significant depletion of ADP in the early stage of reperfusion, 76 the reintroduction of O 2 with reperfusion will greatly increase electron leakage along with a decrease in scavenging capacity, leading to a marked overproduction of • O 2 − and • O 2 − -derived ROS in the mitochondria. Specifically, increased hyperoxygenation induced by reperfusion in the postischemic heart has been detected by in vivo EPR oximetry. 77 The overproduction of mitochondrial ROS also initiates oxidative inactivation of ETC proteins, antioxidant enzymes, lipid peroxidation, and mtDNA damage. Mitochondrial dysfunction caused by this injury to the ETC was marked in the postischemic rat heart. Pretreatment of the heart with the radical trap, 5′,5′-dimethyl pyrroline N-oxide, protected the ETC from postischemic injury, preventing oxidative damage to the ETC that occurred after myocardial ischemia and reperfusion. 78 The activity of mitochondrial aconitase is highly susceptible to oxidative stress, which further predisposes the enzyme as a source of hydroxyl radical. The physiological conditions of myocardial ischemia have been reported to impair aconitase activity in the mitochondria. 79 Postischemic reperfusion increased mitochondrial • O 2 − production and further enhanced oxidative protein damage of aconitase. 79 Therefore, oxidative inactivation of mitochondrial aconitase activity may serve as an additional disease marker of myocardial infarction ( Figure 5 ).
Myocardial ischemia and reperfusion provide a stimulus to alter NO metabolism, including the involvement of endothelial NO synthase, 77, 80 increased nitrite disproportionation, [81] [82] [83] and increased inducible NO synthase expression in chronic reperfusion injury. 80, 84 Therefore, myocardial ischemia and reperfusion indirectly change the balance between NO and • O 2 − in the mitochondria. NO production, subsequent peroxynitrite (ONOO − ) formation, and related protein tyrosine nitration were greatly increased in the mitochondria of postischemic heart. 84, 85 
Mitochondrial Complex I in Postischemic Heart
Complex I is viewed as a major contributor of mitochondrial ROS metabolism in cells. 86 ROS generated by complex I in the cardiovascular system are thus proposed to mediate the physiological effects related to vascular signaling.
However, pathophysiological production of excess ROS by a leak at mitochondrial complex I has been implicated in myocardial infarction ( Figure 5 ). Oxidative impairment of mitochondrial complex I is detected in isolated rat hearts subjected to global ischemia and reperfusion 51, 87 and in animal disease models of myocardial ischemia and reperfusion. 25, 77 In the mitochondria of postischemic hearts, more severe impairment of ETC was observed in complex I, which correlated with mitochondrial dysfunction, diminished NADH-linked state 3 oxygen consumption, and enhanced NADH-linked for complex I-mediated • O 2 − production. 51 In the postischemic heart, ROS-induced damage of mitochondrial cardiolipin and respiratory supercomplex assemblies has been attributed to a defect in complex I activity, increasing electron leakage for complex I-mediated • O 2 − generation, perpetuating a cycle of oxidative damage, and ultimately leading to mitochondrial dysfunction. 87, 88 Furthermore, protein tyrosine nitration of complex I at the flavoprotein fraction and iron-sulfur protein fraction subcomplexes was marked in the postischemic heart, implicating that peroxynitrite-mediated complex I inactivation occurs during myocardial infarction. 85
Mitochondrial Complex II in Postischemic Heart
The role of complex II in mitochondrial ROS production in vivo remains uncertain, and further investigation is required to determine its role in the cardiovascular system. To date, there is no evidence indicating that complex II-mediated ROS metabolism is involved in vascular signaling (unlike complex I). However, specific complex II inhibitors diazoxide or atpenin A5 have been used as pharmacological agents to induce preconditioning-like cardioprotective effects by activating mitochondrial ATP-sensitive potassium (mK ATP ) channels. [89] [90] [91] [92] The basal levels of ROS generated by complex II are likely physiologically relevant in enabling the mitochondria to modulate cardiac function and exert cardioprotection via mK ATP channels ( Figure 5 ).
The defects in mammalian complex II leading to • O 2 − overproduction have been linked with the disease pathogenesis of pheochromocytoma and head-to-neck paraganglioma as well as myocardial infarction. 42, 84, [93] [94] [95] [96] [97] The disease phenotype attributed to a point mutation of complex II is associated with pheochromocytoma and head-to-neck paraganglioma, causing electron leakage from the prosthetic groups or the Qp site in complex II, producing excess ROS and leading to tumor formation ( Figures 3 and 5) .
In animal models of myocardial ischemia and reperfusion injury, oxidative damage of the electron transfer activity of complex II is marked in regions of myocardial infarction. 42, 84, 98 A damage of complex II is associated with loss of FADH 2 -linked oxygen consumption in the postischemic heart. Further evaluation of the redox biochemistry of complex II indicated that alterations of oxidative post-translational modification are present in postischemic myocardium, including deglutathionylation of the 70 kDa FAD-binding subunit (loss of glutathione binding) and an increase in the level of protein tyrosine nitration of the 70 kDa subunit. Because S-glutathionylation of complex II at the FAD-binding subunit decreases electron leakage that leads to • O 2 − generation in vitro, it is thus expected that complex II deglutathionylation that occurs during myocardial ischemia and reperfusion enhances complex II-mediated • O 2 − generation. 42 The overproduction of • O 2 − and NO results in subsequent oxidative inactivation and protein nitration of complex II, which can serve as a disease marker of myocardial infarction. 84
Mitochondrial Complex III in Postischemic Heart
Uninhibited complex III (versus complex I) is considered a more minor source of mitochondrial ROS with a physiological role in the regulation of metabolic dilation. 7 Despite this minor role, the extramitochondrial role and effect of • O 2 − produced at the Q o site are expected to be relevant. Furthermore, electron leakage at complex III has been linked to pharmacological preconditioning by diazoxide via mK ATP channel opening through the inhibition of complex II and promoting transient generation of ROS for signaling at complex III 91 ( Figure 5 ).
Complex III is proposed as one of the major sources for mitochondrial • O 2 − production in postischemic heart ( Figure 5 ). Increased unstable semiqunone radical, • Q o − , is attributed to be a source of • O 2 − . 99, 100 Evidence includes increased lipid peroxidation of cardiolipin required for complex III activity 101 and increased protein tyrosine nitration at the polypeptide of Rieske iron-sulfur protein, 85 which may increase • Q o − formation. Oxidative injury or protein nitration of complex I and complex II weakens the supercomplex interaction with complex III, which can subsequently enhance • O 2 − generation by complex III in the mitochondria of postischemic heart. 51
Mitochondrial Complex IV in Ischemic Heart
• O 2 − production can be mediated by complex IV under ischemic conditions. The activity of complex IV is modulated in response to O 2 tension. A marked decrease in complex IV activity has been measured in the mitochondria of ischemic hearts 21, 51 and submitochondrial particles exposed to hypoxic conditions in vitro. 102 Hypoxic exposure of murine monocyte macrophages results in cAMP-mediated inhibition of complex IV activity. 21 The inhibition of complex IV is accompanied by phosphorylation mediated by protein kinase A (PKA) and markedly increased • O 2 − generation by phosphorylated complex IV. The conditions of myocardial ischemia also activate mitochondrial PKA, enhancing hyperphosphorylation of complex IV, vastly increasing ROS production by complex IV, and augmenting ischemic and subsequent reperfusion injuries 21 (Figure 5 ). Therefore, specific inhibitors of PKA have been proposed to render cardiac protection against ischemia/ reperfusion injury via suppression of the pro-oxidant activity of complex IV. Furthermore, blocking β 1 -adrenoreceptor activation during ischemia/reperfusion reversed PKA-mediated depression of complex IV activity and reduced myocardium at risk for postischemic injury, 79 implying that β 1 -adrenergic stimulation contributes to myocardial ischemic and reperfusion damage via the mechanism of PKA/cAMP-mediated complex IV inactivation. 79
Conclusions and Perspective
Mitochondrial ROS play critical roles in disease pathogenesis and redox signal transduction. Figure 5 summarizes the proposed physiological role and ischemia/reperfusion-related pathophysiological role of mitochondrial ROS generated by complexes I to IV, Δp, and aconitase. Complexes I and III are the most extensively characterized enzyme complexes mediating ROS generation in the mitochondria and seem to be responsible for the majority of mitochondrial ROS in cardiovascular physiology and disease. The primary physiological role of mitochondrial ROS is to mediate intracellular signaling of vascular metabolic dilation in the cardiovascular system. In the disease setting of myocardial ischemia/reperfusion, oxidative injury of complex I with increased tyrosine nitration or protein thiyl radical-dependent S-glutathionylation can weaken supercomplex interaction and enhance ROS production by complex III. Recently, deglutathionylated complex II and phosphorylated complex IV have also been demonstrated to be involved in mitochondrial ROS generation in the disease progression of myocardial infarction. Increased peroxynitritemediated complex II nitration in postischemic heart further supports the role of complex II in ROS generation and disease. ROS mediated by ETC may also synergistically enhance oxidative stress in the mitochondria via induction of the pro-oxidant activity of aconitase. The redox domains of S-glutathionylation in complex I modulate electron leakage that leads to ROS production from FMN and iron-sulfur clusters. The ongoing evaluation of the role of the aforementioned redox domains in normal and postischemic hearts will enable increased understanding of how mitochondrial ROS mediate cellular signaling in cardiovascular physiology and disease.
Further identification of specific redox domains that regulate mitochondrial ROS generation under physiological or pathological conditions is a major frontier in the field of redox regulation and signaling. Currently, specific S-glutathionylated domains of complex I and complex II have been identified. In addition to S-glutathionylation, specific redox modifications such as cysteine nitrosylation 103, 104 and tyrosine nitration have been detected in complexes I to III, but it is currently unknown whether any of these modifications regulates mitochondrial ROS production. Future studies are likely to reveal new layers of complexity, including more specific oxidative posttranslational modifications and more diverse mechanisms of mitochondrial ROS production and regulation, including how oxidative post-translational modifications regulate ROS generation by ETC in vivo, topology of • O 2 − production by ETC, and how • O 2 − production by ETC provokes the pro-oxidant activity of Krebs cycle enzymes such as aconitase. As this frontier of knowledge advances, continued attention to the fundamental processes of mitochondrial ROS production will be needed to understand cardiovascular disease pathogenesis with the goal of developing improved treatments to ameliorate disease.
